• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二尖瓣内皮细胞在内皮间充质转化过程中分泌骨保护素。

Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition.

作者信息

Songia Paola, Branchetti Emanuela, Parolari Alessandro, Myasoedova Veronika, Ferrari Giovanni, Alamanni Francesco, Tremoli Elena, Poggio Paolo

机构信息

Centro Cardiologico Monzino IRCCS, Milan, Italy; Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Milan, Italy.

University of Pennsylvania, Department of Surgery, Philadelphia, PA, USA.

出版信息

J Mol Cell Cardiol. 2016 Sep;98:48-57. doi: 10.1016/j.yjmcc.2016.06.061. Epub 2016 Jun 23.

DOI:10.1016/j.yjmcc.2016.06.061
PMID:27338002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5026583/
Abstract

AIMS

Mitral valve prolapse (MVP) has a prevalence of 3% in the general population, affecting >176 million people worldwide. Despite this, little is known about the molecular and cellular mechanisms involved in the progression of MVP and surgical intervention is the only available option. In this study we investigated the role of osteoprotegerin (OPG) during endothelial to mesenchymal transition (EndMT) in MVP.

METHODS AND RESULTS

VECs and VICs were isolated from posterior mitral valve leaflets of patients undergoing mitral valve repair (n=25). Plasma was collected from 57 subjects (29 controls and 28 MVP patients). Overexpression of OPG during EndMT followed by autocrine effects characterised by reactive oxygen species increment and accelerated migration was documented. In addition, OPG increased VIC proliferation. Finally, OPG plasma levels were significantly higher in MVP patients compared to control subjects and the area under the ROC curve was 0.92.

CONCLUSION

EndMT has been recognised as a possible pathological mechanism for MVP. For the first time, we report the involvement of OPG in cellular and molecular changes in MVP isolated cells. In addition, we detected elevated circulating OPG levels in MVP patients when compared to controls, which supports the hypothesis that OPG is involved in MVP development and progression.

摘要

目的

二尖瓣脱垂(MVP)在普通人群中的患病率为3%,全球受影响人数超过1.76亿。尽管如此,对于MVP进展所涉及的分子和细胞机制知之甚少,手术干预是唯一可用的选择。在本研究中,我们调查了骨保护素(OPG)在MVP的内皮向间充质转化(EndMT)过程中的作用。

方法与结果

从接受二尖瓣修复的患者(n = 25)的二尖瓣后叶分离出血管内皮细胞(VECs)和平滑肌细胞(VICs)。从57名受试者(29名对照者和28名MVP患者)中采集血浆。记录了EndMT过程中OPG的过表达及其以活性氧增加和迁移加速为特征的自分泌效应。此外,OPG增加了VIC的增殖。最后,与对照受试者相比,MVP患者的血浆OPG水平显著更高,ROC曲线下面积为0.92。

结论

EndMT已被认为是MVP可能的病理机制。我们首次报道了OPG参与MVP分离细胞的细胞和分子变化。此外,与对照组相比,我们检测到MVP患者循环中OPG水平升高,这支持了OPG参与MVP发生和进展的假说。

相似文献

1
Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition.二尖瓣内皮细胞在内皮间充质转化过程中分泌骨保护素。
J Mol Cell Cardiol. 2016 Sep;98:48-57. doi: 10.1016/j.yjmcc.2016.06.061. Epub 2016 Jun 23.
2
Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.二尖瓣内皮细胞与间质细胞之间的相互作用可减少内皮-间充质转化和肌成纤维细胞活化。
J Mol Cell Cardiol. 2015 Mar;80:175-85. doi: 10.1016/j.yjmcc.2015.01.006. Epub 2015 Jan 26.
3
Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.人类黏液样二尖瓣脱垂:骨形态发生蛋白 4 在瓣膜间质细胞激活中的作用。
J Cell Physiol. 2012 Jun;227(6):2595-604. doi: 10.1002/jcp.22999.
4
A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.醛固酮/盐皮质激素受体通路在二尖瓣脱垂发展中的新作用。
Circ Res. 2020 Jul 17;127(3):e80-e93. doi: 10.1161/CIRCRESAHA.119.316427. Epub 2020 Apr 24.
5
Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.评价犬 2D 细胞培养作为黏液样二尖瓣变性模型。
PLoS One. 2019 Aug 15;14(8):e0221126. doi: 10.1371/journal.pone.0221126. eCollection 2019.
6
Stress-induced remodelling of the mitral valve: a model for leaflet thickening and superimposed tissue formation in mitral valve disease.压力诱导的二尖瓣重构:二尖瓣疾病中瓣叶增厚和叠加组织形成的模型。
Cardiovasc Res. 2020 Apr 1;116(5):931-943. doi: 10.1093/cvr/cvz204.
7
Valvular interstitial cells suppress calcification of valvular endothelial cells.瓣膜间质细胞抑制瓣膜内皮细胞的钙化。
Atherosclerosis. 2015 Sep;242(1):251-260. doi: 10.1016/j.atherosclerosis.2015.07.008. Epub 2015 Jul 17.
8
Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.白细胞介素-33/ST2 通路的激活对黏液样变性性二尖瓣疾病产生有害影响。
Int J Mol Sci. 2021 Feb 25;22(5):2310. doi: 10.3390/ijms22052310.
9
Mutations in DCHS1 cause mitral valve prolapse.DCHS1基因的突变会导致二尖瓣脱垂。
Nature. 2015 Sep 3;525(7567):109-13. doi: 10.1038/nature14670. Epub 2015 Aug 10.
10
Wnt Site Signaling Inhibitor Secreted Frizzled-Related Protein 3 Protects Mitral Valve Endothelium From Myocardial Infarction-Induced Endothelial-to-Mesenchymal Transition.Wnt 信号通路抑制剂分泌型卷曲相关蛋白 3 可保护二尖瓣内皮免受心肌梗死后内皮向间质转化的影响。
J Am Heart Assoc. 2022 Apr 5;11(7):e023695. doi: 10.1161/JAHA.121.023695. Epub 2022 Mar 29.

引用本文的文献

1
Unveiling the intricacies of cardiac valve pathophysiology.揭示心脏瓣膜病理生理学的复杂性。
Front Cardiovasc Med. 2025 Jul 24;12:1570271. doi: 10.3389/fcvm.2025.1570271. eCollection 2025.
2
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential.心力衰竭的分子机制及其治疗潜力。
Cells. 2025 Feb 20;14(5):324. doi: 10.3390/cells14050324.
3
Single-cell analysis reveals the loss of FABP4-positive proliferating valvular endothelial cells relates to functional mitral regurgitation.单细胞分析显示,脂肪酸结合蛋白4阳性的增殖性瓣膜内皮细胞的缺失与功能性二尖瓣反流有关。
BMC Med. 2024 Dec 20;22(1):595. doi: 10.1186/s12916-024-03791-4.
4
Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology.心血管病理生理学中的内皮细胞向间充质转化。
Int J Mol Sci. 2024 Jun 4;25(11):6180. doi: 10.3390/ijms25116180.
5
Identification of pyroptosis-associated genes with diagnostic value in calcific aortic valve disease.在钙化性主动脉瓣疾病中具有诊断价值的焦亡相关基因的鉴定。
Front Cardiovasc Med. 2024 Jan 25;11:1340199. doi: 10.3389/fcvm.2024.1340199. eCollection 2024.
6
Biology of mitral valve prolapse: from general mechanisms to advanced molecular patterns-a narrative review.二尖瓣脱垂的生物学:从一般机制到高级分子模式——一篇叙述性综述
Front Cardiovasc Med. 2023 Jun 2;10:1128195. doi: 10.3389/fcvm.2023.1128195. eCollection 2023.
7
Enduring Reactive Oxygen Species Emission Causes Aberrant Protein S-Glutathionylation Transitioning Human Aortic Valve Cells from a Sclerotic to a Stenotic Phenotype.持续产生的活性氧会导致人主动脉瓣细胞的蛋白 S-谷胱甘肽化转变,使它们从硬化表型转变为狭窄表型。
Antioxid Redox Signal. 2022 Nov;37(13-15):1051-1071. doi: 10.1089/ars.2021.0133. Epub 2022 Aug 2.
8
MicroRNAs in Valvular Heart Diseases: Biological Regulators, Prognostic Markers and Therapeutical Targets.微小 RNA 在瓣膜性心脏病中的作用:生物学调控因子、预后标志物和治疗靶点。
Int J Mol Sci. 2021 Nov 9;22(22):12132. doi: 10.3390/ijms222212132.
9
Putative Circulating MicroRNAs Are Able to Identify Patients with Mitral Valve Prolapse and Severe Regurgitation.拟循环 microRNAs 能够识别二尖瓣脱垂伴重度反流患者。
Int J Mol Sci. 2021 Feb 20;22(4):2102. doi: 10.3390/ijms22042102.
10
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease.激活素/Smad2 和 3 信号通路及内皮-间质转化在风湿性心脏病瓣膜损伤中的潜在作用。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11648. Epub 2020 Nov 12.

本文引用的文献

1
Osteoprotegerin in Cardiometabolic Disorders.骨保护素与心脏代谢紊乱
Int J Endocrinol. 2015;2015:564934. doi: 10.1155/2015/564934. Epub 2015 May 11.
2
Osteoprotegerin in patients with degenerative aortic stenosis and preserved left-ventricular ejection fraction.退行性主动脉瓣狭窄且左心室射血分数保留患者中的骨保护素
J Cardiovasc Med (Hagerstown). 2015 Jun;16(6):444-50. doi: 10.2459/JCM.0000000000000035.
3
Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.二尖瓣内皮细胞与间质细胞之间的相互作用可减少内皮-间充质转化和肌成纤维细胞活化。
J Mol Cell Cardiol. 2015 Mar;80:175-85. doi: 10.1016/j.yjmcc.2015.01.006. Epub 2015 Jan 26.
4
Osteopontin-CD44v6 interaction mediates calcium deposition via phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis.骨桥蛋白与CD44v6的相互作用通过磷酸化Akt介导非钙化性主动脉瓣硬化患者瓣膜间质细胞中的钙沉积。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2086-94. doi: 10.1161/ATVBAHA.113.303017. Epub 2014 Jul 24.
5
Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.组织蛋白酶 K 介导的 Notch1 激活有助于低氧反应中的血管新生。
Nat Commun. 2014 Jun 4;5:3838. doi: 10.1038/ncomms4838.
6
Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.二尖瓣脱垂的流行病学与病理生理学:对疾病进展、遗传学及分子基础的新见解
Circulation. 2014 May 27;129(21):2158-70. doi: 10.1161/CIRCULATIONAHA.113.006702.
7
Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.斑块钙化调节因子骨保护素和基质Gla蛋白在稳定型心绞痛和急性心肌梗死中的作用
J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):156-62. doi: 10.2459/JCM.0b013e328365b57d.
8
Gross and histological features of excised portions of posterior mitral leaflet in patients having operative repair of mitral valve prolapse and comments on the concept of missing (= ruptured) chordae tendineae.二尖瓣脱垂手术修复患者后二尖瓣叶切除部分的大体和组织学特征,并对缺失(=破裂)腱索的概念进行评论。
J Am Coll Cardiol. 2014 Apr 29;63(16):1667-74. doi: 10.1016/j.jacc.2013.11.017. Epub 2013 Dec 11.
9
Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling.骨保护素通过 MEK/ERK 信号通路促进软骨细胞增殖,并影响 ADAMTS-5 和 TIMP-4 的表达。
Mol Med Rep. 2013 Dec;8(6):1669-79. doi: 10.3892/mmr.2013.1717. Epub 2013 Oct 8.
10
Oxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences.心脏手术成年候选患者的氧化应激与一氧化氮途径:模式与差异
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):923-30. doi: 10.1093/icvts/ivt386. Epub 2013 Sep 7.